Pulmonx Corporation (LUNG)

NASDAQ

$1.76

$--

(0.00%)

Pre-Market

Pulmonx Corporation (LUNG) Live Price Chart

Last updated: ⁦2026-10-20 10:48:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Pulmonx Corporation (LUNG) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1.76, with a market capitalization of $76.45M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.13 to $2.89. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$76.45M
Open	$1.76
Day's High	$69.48
Day's Low	$1.13
Previous Close	$1.75
Volume	2.00
Average Volume	492.96K
P/E Ratio	--
52-Week High	$2.89
52-Week Low	$1.13
Dividend Yield	--
Earnings Date	--

Pulmonx Corporation (LUNG) Pre-Market Stock Price

Pulmonx Corporation (LUNG) is trading at $1.76 in pre-market trading as of 2026-10-20 08:22:00, up 0.29% ($0.00) from the previous close of $1.75

Pre-market trading shows how investors are pricing LUNG before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Pulmonx Corporation (LUNG) 7-Day Stock Price Change

Over the past seven days, Pulmonx Corporation (LUNG) moved from $1.84 to $1.76, representing a decline of 4.62% ($0.09).

The stock traded between $1.72 and $1.93 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 307.07 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

LUNG 52-Week Price Position

Position in Range: 35.5%

52W Low$1.13

52W High$2.89

LUNG is currently trading at $1.76, placing it 35.5% of the way from its 52-week low of $1.13 to its 52-week high of $2.89. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Pulmonx Corporation (LUNG)?

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Pulmonx Corporation Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	296
Exchange	NASDAQ
Company Website	https://www.pulmonx.com

How to Buy Pulmonx Corporation (LUNG) Stock on MEXC

Eligible investors can buy real shares of Pulmonx Corporation (LUNG) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for LUNG and Place Your Order

Open the RealStocks trading page and search for LUNG. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Pulmonx Corporation (LUNG) stock price today?

Pulmonx Corporation (LUNG) is currently trading at $ 1.76, up 0.29% ($0.00) from the previous close of $ 1.75. Intraday prices update in real time during regular trading hours.

2.Is LUNG stock going up or down today?

As of 2026-10-20 08:22:00, LUNG is trading at $ 1.76, up 0.29% ($0.00) from its previous close of $ 1.75. The stock has traded between $ 1.13 and $ 69.48 during today’s regular session. Past price movements do not guarantee future results.

3.What is LUNG pre-market price?

As of 2026-10-20 08:22:00, LUNG is trading at $ 1.76 in pre-market trading, up 0.29% ($0.00) from the previous close of $ 1.75. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is LUNG after-hours price?

As of 2026-10-20 08:22:00, LUNG is trading at $ 1.76 in after-hours trading, up 0.29% ($0.00) from the regular-session close of $ 1.75. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is LUNG stock trading now?

LUNG trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does LUNG sit relative to its 52-week high and low?

Over the past 52 weeks, LUNG has traded between a low of $ 1.13 and a high of $ 2.89. At $ 1.76, the stock is positioned 35.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Pulmonx Corporation in?

Pulmonx Corporation (LUNG) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Pulmonx Corporation's market capitalization and where is it listed?

Pulmonx Corporation is listed on the NASDAQ exchange with a market capitalization of $ 76.45M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is LUNG valued in terms of P/E ratio and EPS?

LUNG trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.12. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Pulmonx Corporation pay a dividend?

Pulmonx Corporation pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.